Published in Obesity and Diabetes Week, November 28th, 2005
According to recent research from Canada, "Metformin is considered contraindicated in patients with heart failure because of concerns over lactic acidosis, despite increasing evidence of potential benefit. The aim of this study was to evaluate the association between metformin and clinical outcomes in patients with heart failure and type 2 diabetes."
D.T. Eurich and colleagues working with the Canada Institute of Health Economics explained, "Using the Saskatchewan Health databases, 12,272 new users of oral antidiabetic agents were identified...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week